Immunoevasive pericytes from human pluripotent stem cells preferentially modulate induction of allogeneic regulatory T cells

Stem Cells Translational Medicine

Volumn 3, Issue 10, 2014, Pages 1169-1181

  Domev, Hagit ^a   Milkov, Irina ^a   Itskovitz Eldor, Joseph ^a   Dar, Ayelet ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Human pluripotent stem cells; Immunomodulation; Pericytes; Regulatory T cells

Indexed keywords

B7 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 7 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOPHENOTYPING; MOUSE; NONHUMAN; PERICYTE; PERIPHERAL BLOOD STEM CELL; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL LINE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NONOBESE DIABETIC MOUSE; SCID MOUSE;

ANIMALS; CELL LINE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, SCID; PERICYTES; PLURIPOTENT STEM CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84908032901     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0097     Document Type: Article

References (67)

1. Corselli M, Chen CW, Crisan M et al. Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol 2010;30: 1104-1109.
2. Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011;686:49-68.
3. Alon R, Shulman Z. Chemokine triggered integrin activation and actin remodeling events guiding lymphocytemigration across vascular barriers. Exp Cell Res 2011;317:632-641.
4. Pober JS, Tellides G. Participation of blood vessel cells inhumanadaptiveimmuneresponses. Trends Immunol 2012;33:49-57.
5. Stark K, Eckart A, Haidari S et al. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' themwith pattern-recognition and motility programs. Nat Immunol 2013;14:41-51.
6. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-313.
7. Tormin A, Li O, Brune JC et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 2011;117:5067-5077.
8. Dar A, Domev H, Ben-Yosef O et al. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 2012;125:87-99.
9. English K, Mahon BP. Allogeneic mesenchymal stem cells: Agents of immune modulation. J Cell Biochem 2011;112:1963-1968.
10. Kimbrel EA, Kouris NA, Yavanian GJ et al. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev 2014;23:1611-1624.
11. English K, Tonlorenzi R, Cossu G et al. Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. Stem Cells Dev 2013;22:512-523.
12. Maier CL, Pober JS. Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses. Arterioscler Thromb Vasc Biol 2011;31:183-189.
13. Tu Z, Li Y, Smith DS et al. Retinal pericytes inhibit activated T cell proliferation. Invest Ophthalmol Vis Sci 2011;52:9005-9010.
14. Ochs K, Sahm F, Opitz CA et al. Immature mesenchymalstemcell-likepericytesasmediators of immunosuppression in human malignant glioma. J Neuroimmunol 2013;265:106-116.
15. Ren G, Su J, Zhang L et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. STEM CELLS 2009;27:1954-1962.
16. Carrade Holt DD, Wood JA, Granick JL et al. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source. Stem Cells Dev 2014;23:1258-1265.
17. Issa F, Robb RJ, Wood KJ. The where and when of T cell regulation in transplantation. Trends Immunol 2013;34:107-113.
18. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001;1:220-228.
19. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815- 1822.
20. Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev 2013;252:12-23.
21. Kingsley CI, KarimM, Bushell AR et al. CD25 +CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002;168:1080-1086.
22. Lu L, Zhou X, Wang J et al. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-b and retinoic acid. PLoS ONE 2010;5:e15150.
23. Wang C, Yi T, Qin L et al. Rapamycintreated human endothelial cells preferentially activate allogeneic regulatory T cells. J Clin Invest 2013;123:1677-1693.
24. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007;7:585-598.
25. Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: Immune evasive, not immune privileged. Nat Biotechnol 2014;32:252-260.
26. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007;110:3499-3506.
27. Akiyama K, Chen C, Wang D et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 2012;10:544-555.
28. Amit M, Carpenter MK, Inokuma MS et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271-278.
29. Amit M, Itskovitz-Eldor J. Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 2002;200:225-232.
30. Novak A, Shtrichman R, Germanguz I et al. Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus. Cell Reprogram 2010;12:665-678.
31. Domev H, Amit M, Laevsky I et al. Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells. Tissue Eng Part A 2012;18: 2290-2302.
32. Hof-Nahor I, Leshansky L, Shivtiel S et al. Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes. J Cell Sci 2012; 125:4640-4650.
33. Melief SM, Schrama E, Brugman MH et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. STEM CELLS 2013;31:1980-1991.
34. Wang J, Ioan-Facsinay A, van der Voort EI et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007;37:129-138.
35. Bacchetta R, Passerini L, Gambineri E et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006;116:1713-1722.
36. Abbas AK, Benoist C, Bluestone JA et al. Regulatory T cells: Recommendations to simplify the nomenclature. Nat Immunol 2013;14:307- 308.
37. Francisco LM, Salinas VH, Brown KE et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009;206:3015-3029.
38. Marie JC, Letterio JJ, Gavin M et al. TGFbeta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005;201:1061-1067.
39. Li MO,Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006;25:455-471.
40. Melero-Martin JM, De Obaldia ME, Allen P et al. Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo. Tissue Eng Part A 2010;16:2457- 2466.
41. Feng J, Mantesso A, Sharpe PT. Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther 2010;10:1441-1451.
42. Al-Lamki RS, Bradley JR, Pober JS. Endothelial cells in allograft rejection. Transplantation 2008;86:1340-1348.
43. Taflin C, CharronD,GlotzDet al.Regulation of the CD4+ T cell allo-immune response by endothelial cells. Hum Immunol 2012;73:1269-1274.
44. Lasala GP, Silva JA, Minguell JJ. Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product. J Thorac Cardiovasc Surg 2012;144:377-382.
45. Kim JH, Jung M, Kim HS et al. Adiposederived stem cells as a new therapeutic modality for ageing skin. Exp Dermatol 2011;20: 383-387.
46. Chen CW, Okada M, Proto JD et al. Human pericytes for ischemic heart repair. STEM CELLS 2013;31:305-316.
47. Katare RG, Madeddu P. Pericytes from human veins for treatment of myocardial ischemia. Trends Cardiovasc Med 2013;23: 66-70.
48. Janebodin K, Zeng Y, BuranaphatthanaW et al. VEGFR2-dependent angiogenic capacity of pericyte-like dental pulp stem cells. J Dent Res 2013;92:524-531.
49. Ayres-Sander CE, Lauridsen H, Maier CL et al. Transendothelial migration enables subsequent transmigration of neutrophils through underlying pericytes. PLoS ONE 2013; 8:e60025.
50. Selmani Z, Naji A, Zidi I et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. STEM CELLS 2008;26:212-222.
51. Amarnath S, Mangus CW, Wang JC et al. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med 2011 3: 111ra120.
52. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: The key to a stable regulatory T-cell lineage? Nat Rev Immunol 2009;9:83-89.
53. Frazier TP, McLachlan JB, Gimble JM et al. Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions. Stem Cells Dev 2014;23:968- 977.
54. Schlenner SM,WeigmannB, RuanQet al. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med 2012;209:1529-1535.
55. Davidson TS, DiPaolo RJ, Andersson J et al. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 2007;178:4022-4026.
56. Zheng SG, Wang J, Wang P et al. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 2007;178: 2018-2027.
57. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007;110:2983-2990.
58. Li B, Samanta A, Song X et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci USA 2007;104: 4571-4576.
59. Chen W, Jin W, HardegenN et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
60. Leibowitz MS, Srivastava RM, Andrade Filho PA et al. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, andCTL recognitioninheadand neck cancer cells. Clin Cancer Res 2013;19:798-808.
61. AskarinamA, JamesAW,Zara JN et al. Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein. Tissue Eng Part A 2013;19: 1386-1397.
62. Mendel TA, Clabough EB, Kao DS et al. Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS ONE 2013;8:e65691.
63. Yu KR, Kang KS. Aging-related genes in mesenchymal stem cells: A mini-review. Gerontology 2013;59:557-563.
64. da Silva Martins M, Piccirillo CA. Functional stability of Foxp3+ regulatory T cells. Trends Mol Med 2012;18:454-462.
65. Sawant DV, Vignali DA. Once a Treg, always a Treg? Immunol Rev 2014;259:173- 191.
66. Engela AU, Hoogduijn MJ, Boer K et al. Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA. Clin Exp Immunol 2013;173:343-354.
67. WuDC, Hester J, Nadig SNet al. Ex vivoexpanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mousemodel. Transplantation 2013;96:707-716.